A cyclic lipo-hexapeptide echinocandin antifungal agent that is used for the treatment
and prevention of CANDIDIASIS.
https://www.has-sante.fr/jcms/p_3196329/fr/micafungine-mylan 2020 false false false France French drugs, generic Micafungin evaluation of the transparency committee micafungin
--- https://pgtmsite.files.wordpress.com/2024/01/es_micafungine_finale_20201202.pdf 2017 Canada drug information Preventive Intervention Biomaterial Treatment Therapy Object Infection Treatment Epoch candida Treatment Study Pediatric Prevention pediatrics Prevention Study Micafungin On Treatment Candida candidiasis, nos During Treatment preventive treatment, nos Micafungin No Treatment for Diabetes Treat infection control pediatrician Treatment Pediatric mycamine GDC Treatment Frequency Terminology
--- http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62450342 2012 France summary of product characteristics package leaflet powders Micafungin
--- http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63197760 2012 France summary of product characteristics package leaflet powders Micafungin
--- https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailOne.php?lang=fr&linkID=SBD00097 2011 false false false Canada drug information powders Micafungin
--- https://www.ema.europa.eu/medicines/human/EPAR/Mycamine 2011 false United Kingdom English French candidiasis, invasive syndication feed treatment outcome drug evaluation drug labeling lipoproteins echinocandins infant echinocandins infusions, intravenous child adult antifungal agents antifungal agents candidiasis candidiasis bone marrow transplantation adolescent aged beta-Glucans pregnancy lipoproteins drug interactions breast feeding fungemia drug evaluation, preclinical drug storage drug compounding drug approval micafungin lipopeptides lipopeptides echinocandins drug evaluation package leaflet summary of product characteristics Micafungin Micafungin